Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aspirin Therapy Interruption Linked To Higher Stroke Risk In Survivors

This article was originally published in The Tan Sheet

Executive Summary

Former stroke sufferers who interrupted aspirin therapy regimens exhibited more than a three-fold increase in risk of a second stroke, according to a study presented Feb. 2 at an American Stroke Association conference in New Orleans

You may also be interested in...



Heart Risk Linked To Cessation Of NSAIDs After Long-Term Use – Study

Interruption of NSAID therapy after long-term use increases risk of primary acute myocardial infarction for a period of several weeks, according to a case-control analysis published in the December Archives of Internal Medicine

Cessation of Antiplatelet Therapy May Increase Severity of Cardiac Events

Coronary artery disease patients who recently stopped use of aspirin or other antiplatelet therapy are at greater risk of death and death/heart attack combined compared to both nonusers and prior users, a study published in the Oct. 19 Circulation finds

People In Brief

Perrigo promotes in pricing, planning

Topics

UsernamePublicRestriction

Register

PS097806

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel